Follow the Data: Identify polyfunctional differences within the development of combination cancer vaccines1

Research Area: Vaccines & immunology research

Development Stage: Discovery

Goal: Identify differences in combination vaccine structures resulting from tumor vaccine activation

[unex_ce_button id="content_10khx0ih9,column_content_611g46odk" button_text_color="#ffffff" button_font="bold" button_font_size="18px" button_width="auto" button_alignment="right" button_text_spacing="1px" button_bg_color="#29acd8" button_padding="15px 30px 15px 30px" button_border_width="0px" button_border_color="#29acd8" button_border_radius="0px" button_text_hover_color="#ffffff" button_text_spacing_hover="1px" button_bg_hover_color="#9cc9d8" button_border_hover_color="#9cc9d8" button_link="https://www.isoplexis.com/request-a-seminar" button_link_type="url" button_link_target="_blank" has_container="" in_column="1"]Request a seminar
to follow our data >[/ce_button]

How our single-cell systems are making a difference

Solution: PSI revealed differences for more accurate evaluation of tumor vaccine efficacy in a preclinical setting

Finding: Nanoparticle vaccine containing tumor antigens can efficiently activate CD8+ T cells and induce polyfunctional CD8+ T cells that are associated with antitumor activity

Follow the data

Single-Cell CD8+ polyfunctionality and PSI are upregulated in NP-vaccinated mouse group relative to Naïve controls. A robust upregulation of polyfunctional (secreting multiple cytokines) human CD8+ T cells in HIS mice immunized with NP/Antigen/Ab was observed, compared to other groups of HIS mice (left).

We observed a statistically significant difference between the NP/Antigen/Ab group and both the Naïve and Antigen groups. The enhanced PSI was predominated by effector proteins.1

[unex_ce_button id="content_om95el0ye,column_content_g32kkdowi" button_text_color="#424242" button_font="bold" button_font_size="18px" button_width="auto" button_alignment="right" button_text_spacing="1px " button_bg_color="#c9c9c9" button_padding="15px 30px 15px 30px" button_border_width="0px" button_border_color="#c9c9c9" button_border_radius="0px" button_text_hover_color="#424242" button_text_spacing_hover="1px" button_bg_hover_color="#e8e8e8" button_border_hover_color="#e8e8e8" button_link="https://isoplexis.com/CellT-P" button_link_type="url" button_link_target="_blank" has_container="" in_column="1"]Download application note
to learn more >[/ce_button]

IsoPlexis finds critical differences

Antigen specific CD8+ T cell detection by tetramer. Splenocytes were isolated from immunized and naïve HIS mice and incubated with antigen peptide-loaded HLA-A*0201 tetramer.

Cell were stained with the following antibodies to human CD45, mouse CD45, human CD3, human CD4, human CD8 and human CD19. The percentage of Melan-A specific human CD8+ T cells was analyzed by Flowjo software.1